Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin and Doxorubicin with or without Paclitaxel after Radiation in Advanced Endometrial Carcinoma
NCT00006011Phase 3Completed
- Sponsor
- GOG Foundation
- Start
- Jul 2000
- Primary completion
- Mar 2010
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Paclitaxel Micelles for Injection in endometrial carcinoma (2 arms), sponsored by GOG Foundation. Primary endpoint: Recurrence-Free Survival. Started Jul 2000; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT00006011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006011.